Answers are grounded in this paper and cite their sources.
The optimal use of routine childhood immunizations in children with malignancy is still a matter of debate. Despite their higher risk of contracting vaccine preventable diseases and of suffering important complications, there is little understanding of the magnitude of the possible benefit of administering active immunization in this population due to a paucity of clinical trial data. Our review focuses on the management of children with cancer and offers some suggestions regarding their vaccination schedules.
No takes yet. Share an insight, caveat, or question.
Ruggiero et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: